Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Biorxiv : the Preprint Server for Biology|January 23, 2024
ACAD10 and ACAD11 enable mammalian 4-hydroxy acid lipid catabolismEdrees H Rashan, Abigail K Bartlett, Daven B Khana, et al.
JAMA Surgery|January 10, 2024
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node StatusRoger Olofsson Bagge, Rasmus Mikiver, Michael A Marchetti, et al.
American Journal of Human Genetics|February 11, 1999
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiencyB S Andresen, S Olpin, B J Poorthuis, et al.
Journal of the American Academy of Dermatology|October 2, 2022
Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort studyAdrienne B Shannon, Cimarron E Sharon, Richard J Straker, et al.
Nature Structural & Molecular Biology|June 19, 2025
ACAD10 and ACAD11 enable mammalian 4-hydroxy acid lipid catabolismEdrees H Rashan, Abigail K Bartlett, Daven B Khana, et al.
Molecular Genetics and Metabolism Reports|January 6, 2025
Identification of a new COQ4 spliceogenic variant causing severe primary coenzyme Q deficiencyMaría Alcázar-Fabra, Elsebet Østergaard, Daniel J M Fernández-Ayala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced SarcomaNicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
Cell|May 6, 2008
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidationJeffrey R Erickson, Mei-ling A Joiner, Xiaoqun Guan, et al.
JAMA Oncology|January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical TrialCiara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Pageof 29